The Active and the Inactive Form of the hAT₁ Receptor Have an Identical Ligand-Binding Environment: An MPA Study on a Constitutively Active Angiotensin II Receptor Mutant

REFERENCES

• Gether U. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr Rev 2000; 21: 90–113
   PubMed Web of Science ®Google Scholar
• Howard A D, McAllister G, Feighner S D, Liu Q, Nargund R P, Van der Ploeg L H, Patchett A A. Orphan G-protein-coupled receptors and natural ligand discovery. Trends Pharmacol Sci 2001; 22: 132–140
   PubMed Web of Science ®Google Scholar
• Parnot C, Miserey-Lenkei S, Bardin S, Corvol P, Clauser E. Lessons from constitutively active mutants of G protein-coupled receptors. Trends Endocrinol Metab 2002; 13: 336–343
   PubMedGoogle Scholar
• Nikiforovich G V, Mihalik B, Catt K J, Marshall G R. Molecular mechanisms of constitutive activity: Mutations at position 111 of the angiotensin AT1 receptor. J Pept Res 2005; 66: 236–248
   PubMedGoogle Scholar
• Schambye H T, Hjorth S A, Bergsma D J, Sathe G, Schwartz T W. Differentiation between binding sites for angiotensin II and nonpeptide antagonists on the angiotensin II type 1 receptors. Proc Natl Acad Sci USA 1994; 91: 7046–7050
   PubMed Web of Science ®Google Scholar
• Schambye H T, von Wijk B, Hjorth S A, Wienen W, Entzeroth M, Bergsma D J, Schwartz T W. Mutations in transmembrane segment VII of the AT1 receptor differentiate between closely related insurmountable and competitive angiotensin antagonists. Br J Pharmacol 1994; 113: 331–333
   PubMed Web of Science ®Google Scholar
• Yamano Y, Ohyama K, Kikyo M, Sano T, Nakagomi Y, Inoue Y, Nakamura N, Morishima I, Guo D F, Hamakubo T, et al. Mutagenesis and the molecular modeling of the rat angiotensin II receptor (AT1). J Biol Chem 1995; 270: 14024–14030
   PubMed Web of Science ®Google Scholar
• Inoue Y, Nakamura N, Inagami T. A review of mutagenesis studies of angiotensin II type 1 receptor, the three-dimensional receptor model in search of the agonist and antagonist binding site and the hypothesis of a receptor activation mechanism. J Hypertens 1997; 15: 703–714
   PubMed Web of Science ®Google Scholar
• Rihakova L, Deraet M, Auger-Messier M, Perodin J, Boucard A A, Guillemette G, Leduc R, Lavigne P, Escher E. Methionine proximity assay, a novel method for exploring peptide ligand-receptor interaction. J Recept Signal Transduct 2002; 22: 297–313
   PubMed Web of Science ®Google Scholar
• Perodin J, Deraet M, Auger-Messier M, Boucard A A, Rihakova L, Beaulieu M E, Lavigne P, Parent J L, Guillemette G, Leduc R, Escher E. Residues 293 and 294 are ligand contact points of the human angiotensin type 1 receptor. Biochemistry 2002; 41: 14348–14356
   PubMed Web of Science ®Google Scholar
• Clement M, Martin S S, Beaulieu M E, Chamberland C, Lavigne P, Leduc R, Guillemette G, Escher E. Determining the environment of the ligand binding pocket of the human angiotensin II type I (hAT1) receptor using the methionine proximity assay. J Biol Chem 2005; 280: 27121–27129
   PubMed Web of Science ®Google Scholar
• De Gasparo M, Catt K J, Inagami T, Wright J W, Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000; 52: 415–472
   PubMed Web of Science ®Google Scholar
• Parnot C, Bardin S, Miserey-Lenkei S, Guedin D, Corvol P, Clauser E. Systematic identification of mutations that constitutively activate the angiotensin II type 1A receptor by screening a randomly mutated cDNA library with an original pharmacological bioassay. Proc Natl Acad Sci USA 2000; 97: 7615–7620
   PubMed Web of Science ®Google Scholar
• Ballesteros J A, Weinstein H. Integrated methods for modeling G-protein coupled receptors. Methods Neurosci 1995; 25: 366–428
   Google Scholar
• Boucard A A, Sauve S S, Guillemette G, Escher E, Leduc R. Photolabeling the rat urotensin II/GPR14 receptor identifies a ligand-binding site in the fourth transmembrane domain. Biochem J 2003; 370: 829–838
   PubMed Web of Science ®Google Scholar
• Bosse R, Servant G, Zhou L M, Boulay G, Guillemette G, Escher E. Sar1-p-benzoylphenylalanine-angiotensin, a new photoaffinity probe for selective labeling of the type 2 angiotensin receptor. Regul Pept 1993; 44: 215–223
   PubMedGoogle Scholar
• Fraker P J, Speck J C, Jr. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun 1978; 80: 849–857
   PubMed Web of Science ®Google Scholar
• Swillens S. How to estimate the total receptor concentration when the specific radioactivity of the ligand is unknown. Trends Pharmacol Sci 1992; 13: 430–434
   PubMed Web of Science ®Google Scholar
• Laemmli U K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–685
   PubMed Web of Science ®Google Scholar
• Blanton M P, Cohen J B. Identifying the lipid-protein interface of the Torpedo nicotinic acetylcholine receptor: secondary structure implications. Biochemistry 1994; 33: 2859–2872
   PubMedGoogle Scholar
• Laporte S A, Boucard A A, Servant G, Guillemette G, Leduc R, Escher E. Determination of peptide contact points in the human angiotensin II type I receptor (AT1) with photosensitive analogs of angiotensin II. Mol Endocrinol 1999; 13: 578–586
   PubMedGoogle Scholar
• Boucard A A, Roy M, Beaulieu M E, Lavigne P, Escher E, Guillemette G, Leduc R. Constitutive activation of the angiotensin II type 1 receptor alters the spatial proximity of transmembrane 7 to the ligand-binding pocket. J Biol Chem 2003; 278: 36628–36636
   PubMed Web of Science ®Google Scholar
• Martin S S, Boucard A A, Clement M, Escher E, Leduc R, Guillemette G. Analysis of the third transmembrane domain of the human type 1 angiotensin II receptor by cysteine scanning mutagenesis. J Biol Chem 2004; 279: 51415–51423
   PubMed Web of Science ®Google Scholar
• Fu D, Ballesteros J A, Weinstein H, Chen J, Javitch J A. Residues in the seventh membrane-spanning segment of the dopamine D2 receptor accessible in the binding-site crevice. Biochemistry 1996; 35: 11278–11285
   PubMed Web of Science ®Google Scholar
• Javitch J A, Ballesteros J A, Weinstein H, Chen J. A cluster of aromatic residues in the sixth membrane-spanning segment of the dopamine D2 receptor is accessible in the binding-site crevice. Biochemistry 1998; 37: 998–1006
   PubMed Web of Science ®Google Scholar
• Javitch J A, Fu D, Chen J, Karlin A. Mapping the binding-site crevice of the dopamine D2 receptor by the substituted-cysteine accessibility method. Neuron 1995; 14: 825–831
   PubMed Web of Science ®Google Scholar
• Sakmar T P, Menon S T, Marin E P, Awad E S. Rhodopsin: insights from recent structural studies. Annu Rev Biophys Biomol Struct 2002; 31: 443–484
   PubMedGoogle Scholar
• Palczewski K, Kumasaka T, Hori T, Behnke C A, Motoshima H, Fox B A, Le Trong I, Teller D C, Okada T, Stenkamp R E, Yamamoto M, Miyano M. Crystal structure of rhodopsin: A G protein-coupled receptor. Science 2000; 289: 739–745
   PubMed Web of Science ®Google Scholar
• Krebs A, Edwards P C, Villa C, Li J, Schertler G F. The three-dimensional structure of bovine rhodopsin determined by electron cryomicroscopy. J Biol Chem 2003; 278: 50217–50225
   PubMed Web of Science ®Google Scholar
• Dorman G, Prestwich G D. Benzophenone photophores in biochemistry. Biochemistry 1994; 33: 5661–5673
   PubMed Web of Science ®Google Scholar